10x Genomics, Inc. Balance Sheet
TXG / Health Care|9 years of annual SEC 10-K data (FY2017-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
10x Genomics, Inc. had $1.0B in total assets and $796M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | $344.1M | $359.3M | $219.7M | $587.4M | $663.6M | $424.2M | $65.1M | $47.9M |
| Accounts Receivable | $47.0M | $87.9M | $114.8M | $104.2M | $85.3M | $51.2M | $33.4M | $28.1M | - |
| Inventory | $56.3M | $83.1M | $73.7M | $81.6M | $60.0M | $30.0M | $15.3M | $8.6M | - |
| Current Assets | $684.5M | $584.4M | $596.0M | $635.0M | $747.6M | $774.4M | $480.8M | $106.2M | - |
| PP&E (Net) | $226.7M | $252.6M | $279.6M | $289.3M | $169.5M | $72.8M | $48.8M | $11.1M | - |
| Goodwill | $4.5M | $4.5M | $4.5M | $4.5M | $4.5M | $0 | - | - | - |
| Total Assets | $1.0B | $918.6M | $965.1M | $1.0B | $1.0B | $929.3M | $605.9M | $124.3M | - |
| Current Liabilities | $153.5M | $117.6M | $127.2M | $131.0M | $110.4M | $118.1M | $63.0M | $32.4M | - |
| Total Debt | - | - | - | - | - | $0 | $29.7M | $25.5M | - |
| Shareholders' Equity | $796.3M | $710.1M | $741.0M | $805.7M | $817.6M | $739.1M | $420.1M | -$220.0M | -$112.5M |